标签： 上海浦东新区品茶

Why do you want to buy a tablet? The tablet is the third screen between the mobile phone and the PC, taking into account the advantages of both. Business trip can easily replace notebook office, review materials at the end of the term, take notes, play games and watch movies on the big screen.

Today, I will bring you a comprehensive evaluation of vivo Pad3 Pro, and see if the new vivo tablet, which combines a 13-inch 3.1K resolution giant screen, a 11500mAh battery, a flagship chip of Tianzhu 9300, an office suite that is interoperable on all platforms, and a blue heart model, can play the flagship role.

13-inch 3.1K giant screen and eight speakers, shocking audio-visual experience.

Vivo Pad3 Pro uses a 13-inch 3.1K resolution display.3:2 golden screen ratio and high refresh rate of 144Hz,It ensures that both delicate text reading and dynamic video playback can provide an unparalleled visual experience.

The peak brightness of 900nit and P3 wide color gamut coverage make the colors more vivid, and support HDR dual-engine technology, which further improves the contrast and layering of the picture.

Such a display effect can ensure users to enjoy clear and bright images, whether indoors or outdoors.

In terms of speakers, vivo Pad3 Pro adopts an audio-level eight-speaker combination of 4 bass units and 4 treble units, which makes it more immersive when watching movies.

Vivo Pad3Pro adopts the "de-crosstalk" sound field widening algorithm, bid farewell to the constraints of headphones, and can also get a spatial audio experience through speakers. Aiming at the peaceful elite and other games, the directional amplification of the sound volume can realize the position identification.

Blue Crystal X Tianji 9300+11500mAh, with strong performance and lasting battery life.

Vivo Pad3Pro is equipped with Blue Crystal X Tianji 9300+LPDDR5X memory and UFS4.0 flash memory.Tianji 9300 is one of the latest flagship chips in the Android market.Its powerful performance needs no elaboration by the author.

Maybe you don’t know what sapphire is yet. Technology stack, the blue crystal chip, as the long-term investment technology brands of vivo, represents the control of vivo on chip technology.

This technology will fully tap the potential of Tianji 9300, and make exclusive adjustments in six major tracks: performance, display, battery life, AI, games and communication.

The flagship chip is usually limited by the narrow internal space of the mobile phone and can’t play its due strength. The space of the tablet is large, and the strength of the flagship chip is completely released.

Not only that, vivo Pad3 Pro also has a high thermal conductivity copper cooling matrix, 37000mm? After all this talk, what is the actual performance of the three-dimensional cooling system with high-power graphite cooling blessing?

In the latest version, the running score of the safety and immunity has reached 2.08 million, which is the TOP level in the current processor.

For the test of game performance, we chose the popular games Genshin Impact and Star Dome Railway to test the frame rate.

During the test, we adjusted the brightness of the screen to automatic brightness, and the test environment was room temperature of 24℃, and set the game quality and frame rate to the highest level.

Half an hour "Star Iron"

Half an hour, Genshin Impact

Genshin Impact and "Star Dome Railway" have a resolution of nearly 1400P, and the whole process runs in 60 frames, and the highest temperature of the back shell is only 35 degrees Celsius. It can be said that vivo Pad3 Pro is the most powerful Android tablet at present.

In addition to these, the vivo Pad3 Pro is also equipped with the largest battery of the current mainstream Android tablet: 11500mAh, which is very scary after the measured battery life.

Under automatic brightness, 8 hours of work time, watching movies online all the time, 50% left after work, which means that watching movies can be used for about 16 hours.

What surprised me the most was the horrible standby ability of vivo Pad3 Pro. I went to work and tested the Genshin Impact frame rate, but I didn’t quit the game screen. The next morning, I found that the battery didn’t drop.

This is because vivo Pad3Pro is equipped with pure background technology, which rewrites the Android kernel, lightens the system and the three-party application background, avoids stealing tasks and unnecessary refreshing in the background, only wakes up the necessary services of users, and adopts "smart sleep" technology to improve the off-screen resource scheduling, which can achieve 70 days of long standby.

In terms of charging, vivo Pad3 Pro is equipped with a 66W fast charge. Let’s take a look at the actual measurement.

After charging for half an hour, the power reached 34%, and it was fully charged in about one and a half hours, and the whole charging power was stable.

Blue heart model +OriginOS4, office comparable to PC.

The productivity attribute of flat panel is one of the reasons why many people place orders. The addition of large model makes the productivity of flat panel go up a step. The blue heart V released last year was finally put into vivo Pad3 Pro.

Blue Heart V has five outstanding functions, which are related to "super semantic search, super question answering system, super writing ability, innovative image generation and deep intelligent interaction" and so on.

First of all, its super semantic search technology is equivalent to an advanced fuzzy search method. Users do not need to input keywords accurately.

Just describe relevant information, such as mentioning "photos taken last summer" or asking "recently saved documents", and Blue Heart V can quickly locate and present relevant photos or files according to these descriptions.

This function is particularly efficient when dealing with a large number of pictures, which not only helps users find specific photos quickly, but also can be used to retrieve special types of pictures such as invoices.

Secondly, the Super Q&A module not only provides a wide range of question answering services comparable to ChatGPT, but also strengthens the humanized content refining function.

In the face of long articles, Blue Heart V can refine and summarize based on web pages, documents or links, and support in-depth question-and-answer interaction within the text.

Furthermore, super writing ability means that Blue Heart Small V can create different styles of text content according to users’ customized needs. What’s more impressive is that it can also generate mind maps of corresponding themes synchronously, providing users with the overall framework and preliminary ideas of project conception.

In addition, the super-drawing function is both practical and interesting. It can not only automatically generate pictures containing the required elements according to the user’s instructions, but also realize a series of automatic matting and editing operations, which greatly simplifies the picture processing flow and is more convenient and efficient than manual adjustment.

Finally, the super intelligent interaction is to seamlessly connect the intelligent experience into various applications and operation details of the mobile phone by integrating into the OriginOS4 operating system, such as providing functions such as big-bang information extraction and accurate matting inside the application. Although these seemingly small function points are actually supported by powerful computing power.

In short, the interaction with Blue Heart V is extremely convenient, whether through the sidebar, floating icon or atomic component, it can be easily called out and communicated with it. There are many ways of communication, including text input, voice dialogue, and even dragging voice clips and documents directly.

Let’s take a look at the exclusive killer level function of vivo — — Vivo office suite.

This time, the vivo office suite ushered in a new upgrade, which was born for cross-device collaboration. You can use the tablet to remotely control the computer, you can also use the tablet to continue the unfinished writing on the Mac, and even you can drag and drop files across devices on your mobile phone, tablet and computer with just one mouse.

Vivo Pad3 Pro also supports remote control of Mac computers, and supports remote control of computers to complete document editing, application operation, computer shutdown and restart.

In addition, vivo Pad3Pro has a built-in NFC portal, so you can easily view and access photos and files of your mobile phone across the screen in your photo album and file management App, and even the mobile phone interface can be projected to the tablet by just touching the upper right corner with your mobile phone.

Enrich accessories, and expand the usage scenarios of tablet computers.

For office productivity, a tablet is not enough. vivo Pad3Pro is equipped with a smart touch keyboard 3 Pro.

This keyboard adopts the configuration of 1.5mm keystrokes, 18mm keystrokes and 15mmx15mm keycaps, with strong typing resilience and spacious layout, which is consistent with the notebook experience.

On the basis of supporting Windows and Mac dual-system shortcut keys, common function shortcut keys are added, such as keeping independent ESC key and backspace key, increasing global and regional quick screen shots, and supporting custom App-related shortcut keys, such as starting the original god with one click. And 6527mm? Oversized touchpad, which supports free manipulation of multiple gestures.

The intelligent touch keyboard can also be a bracket, which supports 0 ~ 140 degree stepless support.

The most praise is that the tablet supports keyboard mapping, and even adapts to some common games. With the mouse, you can completely play Android games with the keyboard and mouse.

Of course, there is a matching stylus — — VivoPencil2, which has ultra-low time delay and 4096-level pressure sensing, can make the pen mark follow the nib without delay and follow the hand smoothly.

finally

On the whole, vivo Pad3Pro has no slots, and the top hardware level at the same price, especially equipped with Tianji 9300, the top processor in Android, ensures smooth AI operation and multitasking.

And the display, performance and endurance performance are excellent, and it is equipped with innovative blue heart model and OriginOS4 system, which gives the tablet strong productivity and convenient operation experience.

It can be seen that vivo has polished the tablet for three generations and spent a lot of thought on the details. The big model just released is integrated into the office section, and the supporting keyboard not only makes more custom buttons, but also supports the mapping of game buttons, taking into account both office and entertainment.

Obviously, vivo thinks about what kind of tablet consumers want, not only the software ecology of Android, but also the light office ability of Windows and Mac, and also the interoperability of mobile computer tablets. This time vivo Pad3 Pro did it.

This article comes from WeChat WeChat official account:Deep blue view (id: mic-sh 366), Author: Gao Yi, editor: Wang Chen, head picture from: vision china.

In May, 2023, with the latest data of the most Alzheimer’s disease drug from Lilly, this century-old pharmaceutical company continued to sound the upward horn, and its market value climbed to the $400 billion mark, becoming the most valuable pure drug enterprise in history.

When the stories in the field of cancer were exhausted, the investors on Wall Street found the track of "losing weight" and continued to write the myth that the pharmaceutical industry will always go up, which also contributed to the market value growth of Novo Nordisk and Lilly this year. Years of hard work in the CNS field has added a icing on the cake to Lilly.

However, Lilly global is flourishing, and the voice of Lilly China seems to be getting smaller and smaller this year.

Lilly’s last big event in China was the 2022 new medical insurance catalogue at the beginning of this year. Four new products/indications successfully entered medical insurance, including two cooperative products from Cinda. In the past year, the only pipeline renewal that can be seen in China, one is RET inhibitor and the other is a hair loss product, which obviously goes against the thickness of Lilly global’s powerful product pipeline.

Photo: Lilly’s Q1 product performance in 2023.

Source: official website, Jibao finishing

From the time point of view, Lilly is one of the first batch of big manufacturers to bet on China. As early as 2012, Lilly moved its R&D center to China, trying to speed up the listing of global products in China. However, the R&D center in China District opened early and closed early. Perhaps it is the long-term single-digit income ratio in China District, which makes this MNC factory unwilling to invest more energy in cultivation;The rise of local enterprises in these years has also had some run-on effects on foreign enterprises to some extent. In 2022, Lilly’s China business contracted to 1.453 billion US dollars, down by 10 percentage points.(Source: Huachuang Securities).

More than courtesy, under the double pressure of competition between VBP and local enterprises in the past two years, the domestic business of multinational giants has shrunk. One is that the speed of introducing products from foreign companies is slower than in previous years, and the other is that the demand for talents is becoming more and more Buddhist.

A headhunter said that since the second half of last year, the recruitment needs of foreign pharmaceutical companies in all functions, whether business or clinical, have declined; Some non-business core positions that were quite popular a few years ago(such as "digital innovation", etc.)In the past two years, it has almost disappeared completely.

The basic executive positions such as medical representatives were originally the most mobile, but the post pattern has not changed much in the past two years. A person who pays attention to this kind of market mentioned that this is related to the slow iteration of new products in the past two years. Even if new products are listed, they are basically handed over to the original team to do it together. For example, BMS set up a separate team for PD-1 in 2018, which has not been seen in the last two years.

However, although Lilly’s pharmaceutical business in China is operated by Buddhism, it does not prevent Lilly from embracing the rapid growth of this emerging domestic market in other ways. For example, Lilly cooperates with Hutchison and Cinda to help them bring their products to the market, even to Europe and America, and use the resources of their own big factories to earn a share of the money; Another example is LAV, which is synonymous with the success of domestic biomedical first-level investment.

Neither the introduction/authorized cooperation nor the next incubation is exclusive to Lilly. Other multinational pharmaceutical companies have been running in China for nearly 30 years, and now they are slowly adapting to the ever-changing new market with some comfortable postures.

First, "retreat to the high-end route"

In January, 2023, the annual meeting of Huizhi, which was formed by the merger of Pfizer’s mature business units Puqiang and Mylan, was held in Macau, with an exceptionally grand scale.

Behind the luxury annual meeting is its solid growth. According to a participant, Huizhi’s in-hospital sales data this year is obviously better than expected, and the business authorities dare not talk about the specific figures too high-profile, but only give a growth curve that looks obviously upward. Last year’s Huizhi, the bonuses of the sales teams were also exceptionally good.

The number of hospital growth data of Huizhi China is unknown, but from the financial report of Huizhi last year, Greater China was in Q4 last year.(after the epidemic)Year-on-year growth reached 10%. Last year, China earned 2.201 billion US dollars, making it the only market with positive year-on-year growth in net profit.

The main driver of the growth of Huizhi China is Lipitor.(atorvastatin)Luo huoxi(amlodipine)And Xanax(Alprazolam)Among them, the first two were included in the national procurement catalogue long ago. This makes the whole market rethink a question:Is volume a good business after all?

Although the head foreign companies represented by Pfizer and AstraZeneca have launched a series of "grassroots" movements in the past few years, in 2021, Pfizer’s grassroots team reached 600 people, and AstraZeneca’s county team reached a maximum of 4,500 people.

At first, everyone’s idea was to be in a vast market with a super large base. Every 1 percentage point increase in penetration rate is a big increase in the overall scale. However, the following nationwide procurement with quantity not only greatly reduced the profit margin of drugs, but also introduced a large number of "barefoot" players who had never paved the way for the market, which made the "grass-roots strategy" of these large foreign companies a decoration.

Considering the welfare and per capita output, the sales efficiency of foreign pharmaceutical companies is inherently inferior to that of local players, so they can only "retreat" to the high-end market.

Of course, choosing a "high-end market" also requires selective capital. "High-end" doesn’t really mean that products are much higher than competitors in quality and clinical data, but more is a process of brand and doctor-patient psychological cognition, which is inseparable from the long-term market education made by these big manufacturers and the dozens of academic forums that have been smashed in the past decade.

Therefore, sales is not a simple "department meeting" and a dinner party. Whether it is a foreign pharmaceutical company or a local rising star, if you really value your products, the work of the marketing department is indispensable. It should be pointed out that this budget often needs to be integrated into the pricing of a drug.

Both centralized purchasing and medical insurance negotiation can solve the problem of "accessibility" to a certain extent, but the effective use of drugs also needs the promotion of pharmaceutical companies themselves.

Back to Pfizer’s business in China, as long as this "high-end" strategy can still operate normally at present, new products from global will be continuously injected and then profits will be contributed to the world.

This kind of "China agent of multinational pharmaceutical companies" business is also the most classic and good game for foreign pharmaceutical companies. Pfizer is doing it, and Takeda, Novartis, GSK and so on are basically following this strategy at present.

When the global products of these multinational pharmaceutical companies are not strong enough, these companies will also make some deeper attempts in China.

Second, BD cooperates to make a fire by the stove.

Among them, the most representative belongs to Merck.

Although the ceiling of tumor immunotherapy and drug K have now become the proper "drug king", Merck has actually had nothing to do with the treatment field of tumor for a long time.

Merck secured the TOP5 position in the world with simvastatin and losartan. Since then, it has been supported by two major categories: anti-infection and vaccine, and has made heavy income in several sub-sectors such as AIDS, hepatitis C and HPV. Therefore, even in the early 21st century, Roche’s three monoclonal antibodies have already begun to take shape, but the proud Merck seems to have no need to know what antibody drugs are, so he met Schering-Plough.(K medicine source prescription)Before, there were almost no macromolecular products in Merck’s laboratory.

In the second decade, biopharmaceuticals slowly moved to the center of the stage. Half of the TOP10 best-selling products in the world were protein drugs, and Merck himself tasted the sweetness of K drugs. However, the cultivation cycle of biomedical technology needs to be calculated in ten years. It is not easy for Merck, which lacks macromolecular genes, to come up with a mature antibody drug platform to adapt to the pipeline development of such a billion-dollar giant in a short time.

So,When ADC took over the immune products and went to the foreground, Merck, who couldn’t wait, had to put down his body and seek external cooperation.

Therefore, Merck found Seagen, the "originator of ADC", because of his great family business. However, Seagen, whose price has been difficult to negotiate, ended up with Pfizer, which paid an extra $12 billion directly to intercept Hu Merck.

Merck, on the other hand, had to focus on Collen, an old friend of China, and directly won nine ADC molecules in one breath, which was less than a quarter of Seagen’s acquisition even if all the total package prices were included. Merck’s deal could not be said to be uneconomical.

In May this year, Ms. Ji Juan, the head of Merck’s business development and authorization in Greater China, mentioned at the third Sequoia Global Medical and Health Industry Summit: "Merck’s product introduction is distributed in various treatment fields, clinical stages and different mechanisms." Merck will not only focus on one or two big therapeutic fields now, as long as things are good, it can be digested. To some extent, it also reflects the comprehensiveness of large factories.

Merck’s eclectic products contributed half of the company’s revenue last year. If the ADC field continues to deepen and become more and more accepted by the global market, a considerable part of Merck’s tens of billions of dollars in revenue in the future may come from laboratories in China.

With the domestic R&D-clinical capability reaching a higher level, it is not uncommon for China to feed back the world.License out has also become a commonplace topic.But an interesting point is that the number of domestic and foreign authorizations and the total amount of cooperation are increasing, but the down payment is decreasing.

On the one hand, "returns" have become more frequent in the past two years, such as the ADC of Genting Xinyao, the PD-1 of Cinda, and the BTK of Nuocheng Jianhua, which has reduced the certainty of this authorized cooperation;

On the other hand, whether local enterprises or partners, everyone is more willing to seek innovation in the model, and both sides make a concession and take what they need to tell the story more satisfactorily. For example, Cinda and Sanofi, and for example, Merck and Columbine Botai, both of which are mixed with equity transactions.

However, in a mature market, the BD transaction of License in/out itself is a very common thing. The details such as transaction amount, down payment, object and method only reflect the strategic choice of participants at this time node. When the valuation is high, the efficiency of self-research is higher than that of external mergers and acquisitions, and when the industry is deserted, large companies with spare money are more suitable for expansion.(rather than self-research).

The diversification and normalization of BD cooperation shows that the biomedical market in China is slowly maturing.

Third, hatch in person

After the dissolution of AstraZeneca China R&D Center, it became Di Zhe. After running for less than three years, it landed in science and technology innovation board and rose from the bottom of last year, and its share price tripled at the highest. AstraZeneca, as a major shareholder accounting for 26% of the shares, in addition to the premium on financial investment, it can carry out in-depth cooperation on the product pipeline through Dizhe in the future.

More importantly, AstraZeneca can use the business card Dizhe to do some deeper cooperation in finance and project mergers and acquisitions in the future. A typical example is AstraZeneca Zhongjin Medical Industry Fund, which was established with CICC the year before last. It is very comfortable in fundraising and investment, and currently holds 13 medical and medical projects. AstraZeneca’s business in China is increasingly diversified.

In addition to AstraZeneca, Deqi Medicine, which was established in 2016 with the support of Xinji Medicine, a leading global biopharmaceutical company, also has a little "incubation nature".

The founder of Deqi Medicine comes from the R&D executives of Xinji. Half of the main projects come from Xinji, and some of the money from Angel Wheel just landed is given by Xinji. However, considering that Xinji’s share in Deqi was less than 6% at the time of IPO, it was not controlled, but it was an enterprise hatched by Xinji after all.

What can be controlled is called "incubation", and what can’t be controlled can only be called "deep cooperation"In addition to Deqi, another big hand of Xinji is Baekje.

In 2017, Xinji awarded a cooperation with a total amount of US$ 1.393 billion, which not only helped Baekje just listed on the US stock market, but also boosted its prosperity. At the same time, it used its own mature products and the commercialization team of Xinji Company acquired by Baekje in China to promote Baekje to establish a commercialization system.After this cooperation, Baekje was arrogant all the way, and the market value of US stocks almost caught up with Japan’s MNC giant Takeda. However, Xinji itself sold herself to BMS in 2019, and this cooperation was suspended. The "breakup" between Xinji and Baekje may have been doomed.

Amgen replaced Xinji and continued to cooperate with Baekje in depth, which is also "giving money and products". Perhaps it is more optimistic about the potential of this company. Unlike Xinji, Amgen directly turned itself into a major shareholder of Baekje.

It is worth mentioning that nowadays, the cooperation between multinational pharmaceutical companies and local companies is more and more diversified, not limited to one or two ways.

For example, Baekje and Amgen are deeply bound, and Baekje also supports the construction of its tumor pipeline to Novartis License out products, while the latter, while the pipeline is supplemented, can also empower Baekje to commercialize in the world;

Furthermore, AstraZeneca’s cooperation with the local area can be described as "dazzling": green leaf exchange products, binding with Internet channel geeks, introducing the ADC of No.1 and No.3, and introducing the ADC of Connoa/Lepu Bio at the same time … As for other sales and market cooperation, there are countless more.

The reason why foreign companies are more and more willing to play is that the rules of the game are more and more fair.

In the past two decades, a few domestic enterprises have the ability to develop compound technology to meet the differentiated needs of the low-level market that foreign pharmaceutical companies cannot cover. Most so-called pharmaceutical companies only earn coins in the circulation field.

With the improvement of the independent ability of the pharmaceutical industry, the wave of innovation is superimposed. From following imitation to innovation self-sufficiency to "in China for global", the productivity of foreign companies’ products is no longer suppressed, and the policy protection of local pharmaceutical companies is becoming more and more negligible. Everyone is playing together at the same level and conditions.

Behind this is the growing maturity of the entire pharmaceutical industry in China.

Maturity also means that local pharmaceutical companies need to abandon the luck of "home advantage" and come up with 100% strength to compete with these large foreign companies with a history of 100 years.

This article comes from WeChat WeChat official account:Deep blue view (id: mic-sh 366), Author: Gao Yi, Editor: Wang Chen

Alleviate the difficulty of docking production and marketing, and promote agricultural products to leave the village
Internet plus adds new vitality to agriculture.

On July 2nd, the State Council held a routine briefing on the State Council’s policies, introducing the related situation of further promoting "Internet+agriculture" to promote the integration and development of rural primary, secondary and tertiary industries. Qu Dongyu, Vice Minister of Agriculture and Rural Affairs, Keke, Director of Market and Economic Information Department of Agriculture and Rural Affairs, and Zong Jinyao, Director of Agricultural Products Processing Bureau attended the meeting and answered questions from reporters.

Qu Dongyu introduced that in the next step, the Ministry of Agriculture and Rural Affairs will promote the project of "internet plus" agricultural products leaving the village, carry out the project of "information entering the village and entering the household" in depth, organize the national training of farmers’ mobile phone application skills, continue to run the "double innovation and double innovation" Expo, promote the in-depth development of mass entrepreneurship and innovation in rural areas, expand the scale, scope and content of regional experiments of agricultural Internet of Things, build big data of the whole industrial chain of important agricultural products, do a good job in monitoring and early warning of agricultural information, and promote the integrated development of rural primary, secondary and tertiary industries

Grasp the standardization of agricultural products and guide production and sales with big data.

"The top priority of’ Internet+Agriculture’ is to promote agricultural products out of the village." Qu Dongyu said that the Ministry of Agriculture and Rural Affairs will help farmers to sell high-quality, qualified and distinctive agricultural products to cities. This requires us to work with relevant departments to formulate policies, including traceability and standardization of the quality and safety of agricultural products, grading packaging and cold chain logistics, to ensure that agricultural products leave the village and can be sold at a good price.

"China is a big country with small farmers. How to connect with the big market, the Internet provides a rare historical opportunity and means." Qu Dongyu said that the Ministry of Agriculture and Rural Affairs will cooperate with the village-leaving project to help agricultural products from poor areas and other distinctive areas connect with hundreds of millions of small farmers in the big market, and work with relevant departments to issue guidance on agricultural products leaving the village as soon as possible.

The difficulty of unsalable agricultural products has been puzzling the development of agriculture and the increase of farmers’ income in recent years. "Standardization and grading pretreatment of agricultural products are prerequisites for realizing transactions." Qu Dongyu said that in recent years, the Ministry of Agriculture and Rural Affairs has been focusing on the construction of wholesale markets for agricultural products and improving the standard level of wholesale markets. At the same time, the construction of regional brand, enterprise brand and product brand of agricultural products has also been carried out.

"Agricultural and rural big data is massive. We should provide authoritative government information services and useful business information services through data collection, collation, development and utilization." Qu Dongyu introduced that the Ministry of Agriculture and Rural Affairs has organized 21 provinces and cities to carry out big data experiments on eight major agricultural products, improve the monitoring and early warning system, publish the wholesale price index of agricultural products every day, publish the market supply and demand report of 19 agricultural products and the supply and demand balance table of five products every month, and gradually realize the use of data management services to guide production and sales.

Establish a beneficial agricultural information society to open up the digital gap between urban and rural areas

"One embodiment of the urban-rural gap and dual structure is the digital divide between urban and rural areas." Keke pointed out that in view of this difficulty and pain point, the Ministry of Agriculture and Rural Affairs, on the basis of summing up the experience of "12316 agriculture, countryside and farmers information service hotline", implemented the project of information entering villages and households. At present, the whole province has been promoted in 18 provinces. There are 204,000 villages in China that have set up information clubs for farmers, accounting for 1/3 of the administrative villages in the country, which mainly provide public welfare services, convenience services, e-commerce and training experience.

Through the system of province as the core, city and county as the link and village as the node, the information service network covering the people, new agricultural business entities and agricultural socialized service organizations has been established, which can effectively improve rural governance.

In the next step, the Ministry of Agriculture and Rural Affairs will speed up the construction of the information society for benefiting farmers and ensure that more than 80% of the administrative villages in the country will be covered by 2020. Strengthen the training of selecting and appointing village-level information officers, give priority to selecting and appointing information officers from those who return to the countryside and rural youth who are interested in information services, and carry out training and enhance their abilities. Improve the construction and operation mechanism, mobilize the participation enthusiasm of enterprises and other social forces, and achieve sustainable development. Strengthen departmental cooperation, gather information resources related to agriculture, build a public service platform, and improve the service function and level of Yi Nong Information Society.

Grasp industrial integration and upgrade agricultural and rural economy

"In the past, agriculture was focused on agriculture, and farming was carried out on the farming industry, without linking processing, circulation and sales." Zong Jinyao believes that "internet plus" can use market demand and consumption information to guide production, processing and circulation, enhance the interconnection of primary, secondary and tertiary industries, and at the same time introduce the concept and technology of "internet plus" into agriculture, promote the deep integration of agriculture and other industries, and build an upgraded version of agricultural and rural economy.

Qu Dongyu said that in recent years, the Ministry of Agriculture and Rural Affairs has organized nine provinces to carry out regional trials of agricultural Internet of Things, and issued 426 technologies and application models of agricultural Internet of Things products to save costs and increase efficiency. In the cotton field planting of Xinjiang Production and Construction Corps, the Internet of Things technology is integrated and applied, and the comprehensive application benefits increase 210 yuan per mu. At the same time, agricultural and rural e-commerce has developed rapidly, and new formats have flourished. By the end of 2017, the comprehensive demonstration of e-commerce in rural areas had supported 756 counties, the retail sales of rural networks reached 1.25 trillion yuan at the end of last year, and the e-commerce of agricultural products was moving towards the 300 billion yuan mark, driving the number of employed people to exceed 28 million.

Since 2015, the Ministry of Agriculture and Rural Affairs has organized and implemented the subsidy policy for the integration development of the first, second and third industries. So far, it has arranged a total of 12.1 billion yuan to support the integration development projects. In 2017, the output value of China’s agricultural product processing industry reached 22 trillion yuan, and the business income of leisure agriculture and rural tourism reached 740 billion yuan. Various new formats and models such as creative agriculture, sharing agriculture and e-commerce emerged one after another.

In the next step, the Ministry of Agriculture and Rural Affairs should continue to implement the promotion action of rural industrial integration development: implement policies to guide integration, promote the implementation of support policies such as finance, finance, taxation, scientific and technological talents, land use and electricity consumption, support a number of counties, towns and villages, develop rural integration development pilot areas and demonstration parks, and cultivate integrated development enterprises; Develop industrial support and integration, encourage the development of breeding, processing and circulation, leisure tourism, e-commerce, healthy old-age care, health preservation and other industries, and build a rural industrial system; Improve the mechanism to drive integration, guide enterprises and farmers to improve the interest linkage mechanism through order agriculture and share dividends, and provide strong support for rural revitalization. (Reporter Chang Qin)

Since its listing in May this year, Xingjiyuan ET has successfully occupied a place in the new energy medium and large SUV market with its extended range, pure electric dual-power option and lower price at the same level.

In order to further enrich consumers’ choices, at the 2024 Guangzhou Auto Show, the new Star Era ET extended-range four-wheel drive was pre-sold, and the pre-sale price range was 249,800-299,800 yuan. Together with the previously introduced extended-range rear drive and pure electric rear drive/four-wheel drive, the number of models increased to 12, which can be said to be very rich.

The new Star Era ET extended-range four-wheel drive is equipped with Chery’s self-developed extended-range special engine, with a thermal efficiency of 44.5% and a rated power of 115kW, which can realize 1L oil power generation of 3.67kWh and can add 92 # gasoline. For reference, at present, the range extender 1L oil with better performance in the industry can generate about 3.3kWh.

The new car is equipped with Snow Leopard four-wheel drive system. The comprehensive power of the front and rear dual motors can reach 345kW, the acceleration time of zero hundred is only 4.8 seconds, and the electronic limited slip response speed is 0.05 seconds, which is more suitable for places with rainy and snowy weather. This extended-range system is mounted on the new Star Era ET extended-range four-wheel drive. It is officially claimed that the pure electric cruising range is 240km under CLTC working condition, the comprehensive cruising range can reach 1,500 km, and the fuel consumption of feed under WLTC working condition is 5.9L/100km.

In terms of charging, 20%-80% SOC takes only 17.5 minutes, 12 minutes faster than peers, and the pure battery life increases by 144km, 44km more than peers. Even though the battery can still work normally at minus 35, it only takes 61 minutes to charge to 80% at minus 20, and the industry average time is 78 minutes.

As a medium and large five-seater SUV, the space performance of the new Star Era ET extended-range four-wheel drive naturally goes without saying. Let’s look at the data first. The effective cabin space is 3.45 m, and the whole vehicle has 36 storage spaces. It is also equipped with a 1.27㎡ panoramic canopy that can isolate 98.5% infrared rays and 99.9% ultraviolet rays, and an electric sunshade is added.

Besides space, comfort is equally important. The new Star Era ET extended-range four-wheel drive is equipped with Yuntai intelligent chassis, which has four core technologies: cloud architecture, intelligent control chassis, high-efficiency braking and intelligent power. The chassis adopts all-aluminum design, and is equipped with front double wishbone and rear five-bar suspension. It also has CDC electromagnetic vibration reduction system and IAS intelligent air suspension, taking into account the balance of handling and comfort.

The seat in the car is made of Nuprima micro-velvet matte leather, and is equipped with luxury audio headrest and 16-way electric floating zero-gravity passenger seat. Even the rear seats have four-way electric adjustment, which can take care of the whole family’s travel.

In addition, the new Star Era ET extended-range four-wheel drive adopts intelligent air management and intelligent thermal management system, which can actively monitor the concentration of PM2.5 in the car and purify the air inside the car. It is also equipped with a movable star bar and a master sound system of Lion Melody, so that users can enjoy the quiet space while taking a nap, while taking into account the listening experience.

In terms of intelligence, the new Star Era ET extended-range four-wheel drive is based on Chery’s latest generation EEA 5.0 electronic and electrical architecture, which can realize global SOA service, equipped with Qualcomm Snapdragon 8295 chip, and also upgraded the brand-new EXEED OS system, adding new practical functions such as split screen, full-brand mobile phone screen projection and camping mode.

In addition, it is equipped with 30 high-performance sensors including ultra-long-range high-precision laser radar, high-precision millimeter-wave radar, high-definition camera, etc. At the same time, it adopts dual NVIDIA DRIVE ORIN chips with a computing power of 508TOPS, which can realize full-scene intelligent driving assistance such as high-speed navigation assistance, urban navigation assistance and intelligent parking.

It is worth mentioning that the new Star Era ET extended-range four-wheel drive integrates intelligent driving and intelligent cockpit AI model, and users can complete intelligent driving control by talking to virtual voice assistants in intelligent driving.

If Chery Group is compared to the pyramid, then the Star Way brand is located at the top of the pyramid, and the Star Age sequence is the pearl on the top. As the second product of the Star Age series and the first SUV model, Star Age ET is backed by the "big tree" of Chery Group, which can be said to be the epitome of Chery Group’s 27-year spire technology.

The previously listed Star Era ET extended-range rear drive and pure electric rear drive/four-wheel drive have successfully gained a foothold in the new energy medium and large SUV market, and after the launch of the new Star Era ET extended-range four-wheel drive, it is hoped that the sales volume will be further improved.